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Abstract
Heart failure (HF) with diastolic dysfunction has been attributed to increased myocardial stiffness that limits proper filling of the ventricle. Altered cross-bridge interaction may significantly contribute to high diastolic stiffness, but this has not been shown thus far.
Cross-bridge interactions are dependent on cytosolic [Ca 2+ ] and the regeneration of ATP from ADP. Depletion of myocardial energy reserve is a hallmark of HF leading to ADP accumulation and disturbed Ca 2+ -handling. Here, we investigated if ADP elevation in concert with increased diastolic [Ca 2+ ] promotes diastolic cross-bridge formation and force generation and thereby increases diastolic stiffness. ADP dose-dependently increased force production in the absence of Ca 2+ in membrane-permeabilized cardiomyocytes from human hearts. Moreover, physiological levels of ADP increased actomyosin force generation in the presence of Ca 2+ both in human and rat membrane-permeabilized cardiomyocytes. Diastolic stress measured at physiological lattice spacing and 37°C in the presence of pathological levels of ADP and diastolic [Ca 2+ ] revealed a 76±1% contribution of cross-bridge interaction to total diastolic stress in rat membrane-permeabilized cardiomyocytes.
Inhibition of creatine kinase (CK), which increases cytosolic ADP, in enzyme-isolated intact rat cardiomyocytes impaired diastolic re-lengthening associated with diastolic Ca 2+ -overload. In isolated Langendorff-perfused rat hearts, CK-inhibition increased ventricular stiffness only in the presence of diastolic [Ca 2+ ]. We propose that elevations of intracellular ADP in specific types of cardiac disease, including those where myocardial energy reserve is limited, contribute to diastolic dysfunction by recruiting cross-bridges even at low Ca 2+ and thereby increase myocardial stiffness.
Abbreviations
HF, Heart failure; CK, Creatine kinase; PCr, Phosphocreatine; LVEDP, Left ventricle end-diastolic pressure; IDCM, idiopathic dilated cardiomyopathy; F pas , Passive tension; ADP-F total , ADPstimulated total tension; ADP-F act , ADP-active tension; Ca 2+ -F total , Ca 2+ -stimulated total tension;
Introduction
Heart failure (HF) is a clinical syndrome defined as the inability of the heart to sufficiently supply blood to organs and tissues (McMurray & Pfeffer, 2005) . While contractile dysfunction is present in about half of the HF patient population almost all patients show impaired diastolic function (McMurray & Pfeffer, 2005; Borlaug & Paulus, 2011) .
Pathophysiological mechanisms which have been related with diastolic dysfunction involve alterations of the passive properties of the ventricular wall, including high titin-based myofilament passive stiffness and collagen deposition, and slow rates of myocardial relaxation due to increased myofilament Ca 2+ -sensitivity and impaired Ca 2+ -reuptake (Leite-Moreira, 2006; van Heerebeek et al., 2012; Hamdani & Paulus, 2013) .
Depletion of myocardial energy reserve represents a major cause of dysfunction of the failing human heart (Neubauer, 2007) . In the healthy heart, creatine kinase (CK)
catalyzes the transfer of phosphate from phosphocreatine (PCr) to ADP, thereby regenerating ATP, while preventing accumulation of cytosolic ADP (Allen & Orchard, 1987) . ATP is essential for cross-bridge cycling. As little as 0.1 mM ATP is sufficient for cross-bridge detachment and sarcomere relaxation (Cooke & Bialek, 1979) . The relatively high myocardial in vivo ATP levels in both healthy (8-11 mM) and various pathological conditions (7-10 mM) (Tian et al., 1997b; Spindler et al., 1998; He et al., 2007) indicate that reductions in ATP levels are unlikely to directly impair relaxation of the heart muscle.
Notably, HF patients with diastolic dysfunction (Smith et al., 2006; Phan et al., 2009 ) and animal models of HF (Hamman et al., 1995; Spindler et al., 1998; Horn et al., 2001; He et al., 2007) show that the reduced PCr/ATP ratio (a parameter of myocardial energy reserve measured in vivo) is mostly explained by a severe reduction in PCr (up to 50%) rather than changes of ATP (≤25%). Reducing PCr or experimental inhibition of CK activity is causally linked to the development of HF, as it elevates left ventricle end-diastolic pressure (LVEDP), reduces contractile reserve and increases mortality in rats (Hamman et al., 1995; Tian et al., 1997a; Horn et al., 2001) . Activity of CK isoforms is decreased by 50% in animal models of HF (Khuchua et al., 1989; Nascimben et al., 1995; Neubauer et al., 1995) . The consequence of low PCr and/or a reduced CK activity is that cytosolic levels of ADP will increase. Indeed, increases in [ADP] of >50% have been reported in several 5 animal models of HF (Tian et al., 1997b; Spindler et al., 1998; He et al., 2007) . Selectively increasing ADP levels without altering cytosolic ATP levels has been shown to increase LVEDP and limit myocardial relaxation in rats (Tian et al., 1997a; Tian et al., 1997b) .
These studies support the idea that limited myocardial energy reserve via elevations of ADP may represent a likely cause of diastolic dysfunction. However the exact pathophysiological mechanism has not been elucidated.
Intriguingly, ADP can stimulate tension generation, in the absence of Ca
2+
, in membrane-permeabilized rabbit skeletal muscle fibers (Shimizu et al., 1992) and bovine cardiac muscle (Fukuda et al., 1996; Fukuda et al., 1998) . These findings indicate that ADP accumulation, as a consequence of disturbed myocardial energy reserve, may lead to incomplete relaxation during diastole caused by residual actomyosin interactions. However, in HF, the accumulation of ADP occurs concomitantly with disturbed Ca
-handling (Beuckelmann et al., 1992; Shannon et al., 2003; Undrovinas et al., 2010) . ] increase diastolic stiffness.
Methods

Ethical Approval
Human samples were obtained after written informed consent and with approval of St and UK Home Office and local ethical review.
Myocardial human samples
Human left ventricular (LV) tissue was obtained during heart transplantion surgey from end-stage failing patients with idiopathic dilated cardiomyopathy (IDCM). Tissue was immediately frozen and stored in liquid nitrogen.
Isometric force measurements in membrane-permeabilized single human cardiomyocytes
Small human cardiac tissue samples (N=3) were thawed in relaxing solution and cardiomyocytes were mechanically isolated by tissue disruption as described previously (van der Velden et al., 1998) . Cardiomyocytes were chemically permeabilized by incubation for 5 minutes in relaxing solution containing 0.5% (v/v) Triton-X100 and glued between a force transducer and a piezoelectric motor. Isometric force measurements were subsequently performed on single cardiomyocytes at a sarcomere length of 2.2 μm.
Absolute force values were normalized to cardiomyocyte cross-sectional area and expressed as developed tension (in kN/m 2 ). Passive tension (F pas ) was determined by allowing the cardiomyocyte to shorten by 30% of its length in relaxing solution. ADPstimulated total tension was determined by activating the cardiomyocyte at 10 mM ADP (ADP-F total , Figure 1A ). Similarly, Ca 2+ -stimulated total tension was determined by activating the cardiomyocyte at 32 μM Ca
2+
(Ca 2+ -F total ; Figure 1A ). Active tension (Ca 2+ -F act or ADP-F act ) was calculated as F act =F total -F pas . In addition, the rate of force redevelopment (ktr) was determined using a slack-restretch test as follows: after steady state force was reached, cardiomyocytes were allowed to shorten to 70% of their original length within 1 ms and then re-stretched to the original length after 30 ms. A single exponential was fitted to determine the rate constant of force redevelopment: ktr was determined at maximal and submaximal [Ca 2+ ] in the presence of ADP to assess crossbridge cycling kinetics.
Experimental solutions
The composition of all solutions was calculated based on a computer program similar to that described previously (Papp et al., 2002) . The pH of all solutions was adjusted to 7.1 at 15ºC with KOH and ionic strength was adjusted to 180 mM with KCl. Bialek, 1979) ) and consecutively increased the [ADP] from 1 to 10 mM. We used a maximum [ADP] of 10 mM, since ADP-stimulated tension was maximal at 10 mM ADP with 1 mM ATP in bovine cardiac muscle (Fukuda et al., 1996; Fukuda et al., 1998) .
Data analysis of isometric force measurements
Ca
2+
-and/or ADP-force relations were determined by a non-linear fit procedure using a modified Hill equation using KaleidaGraph version 3.6 (Synergy Software, Reading, PA)
as follows accordingly:
where P is steady-state force. P 0 denotes the steady isometric force at either saturating -and/or ADP-sensitivity is denoted as EC 50 .
Isolation of intact rat ventricular cardiomyocytes
Intact rat cardiomyocytes were isolated using collagenase digestion of hearts as described previously (King et al., 2011) . Briefly, adult wild-type male Wistar rats (N=7) weighing ~300 grams were euthanized with isoflurane and hearts were quickly removed and rinsed in cold isolation-Tyrode solution (composition: 130 mM NaCl, 5.4 mM KCl, 3 mM NaPyruvate, 25 mM HEPES, 0.5 mM MgCl 2 , 0.33 mM NaH 2 PO4, 22 mM glucose) containing 0.2 mM EGTA (Tyrode-EGTA) and pH 7.4. The heart was then cannulated via the aorta to the Langendorff apparatus and perfused for 2 min with Tyrode-EGTA at 37ºC.
Thereafter, the heart was perfused with enzyme-Tyrode solution consisting of Tyrode solution, 1.2 mg/ml collagenase (Type II, 265 U/mg; Worthington Biochemical, NJ, USA) and 50 μM CaCl 2 for a period of 7 min. The right ventricle and atria were removed, and the LV was cut into small pieces and triturated with a plastic Pasteur pipette for 3 min in stopping buffer solution 1 (SB-1; composition: Tyrode solution, 0.6 mg/ml collagenase, 100 μM CaCl 2 and 10 mg/ml bovine serum albumin (BSA)). The cell suspension was filtered through a 300 µm nylon mesh filter into a 50 ml Falcon tube and centrifuged for 1 min at 27x g (20-23ºC -force relations without and with ADP, and the rate of cross-bridge cycling was determined as previously described for human samples.
Diastolic stress measurements in membrane-permeabilized rat cardiomyocytes
Single cardiomyocytes isolated by collagenase digestion from adult wild-type male Wistar rats (N=5) were used. Cardiomyocytes were chemically permeabilized with 0.5% (v/v) Triton-X100 as indicated above and isometric force measurements were performed in single cardiomyocytes stretched from 1.8 to 2.4 μm sarcomere lengths. Experiments were performed at 15ºC to replicate conditions currently employed to study diastolic stiffness/stress and at a higher, more physiological temperature of 37ºC. Since membranepermeabilization causes myofilament lattice expansion, experiments were also performed with the osmotic agent dextran T500 (4%, w/v) that compresses the myofilament lattice to physiological levels (Irving et al., 2000) . Additionally, 30 μM of the cross-bridge inhibitor blebbistatin was used to assess the contribution of cross-bridge formation to passive stress. were determined.
Experimental protocol for unloaded rat cardiomyocyte measurements
To test the hypothesis that ADP accumulation impairs myofilament function in cardiomyocytes with intact membrane, a protocol was established using a low dose of an irreversible inhibitor of CK, iodoacetamide. Specifically, 5 mM fresh iodoacetamide (I6125, Sigma) was dissolved in Tyrode buffer and perfused (at 1 ml/min) for 3 min, delivering a total dose of 15 μmoles/3 ml. This drug has well-characterized effects on the ATP-regeneration system, such that it significantly increases [ADP] without altering ATP, PCr, inorganic phosphate and pH levels in isolated perfused hearts (Tian et al., 1997a; Tian et al., 1997b) . ADP is estimated to be lower than 73 μM at this dose range (Tian et al., 1997a) .
Two protocols were used to test the effects of CK-inhibition ( Fig. 5 ).
Cardiomyocytes were paced at 1Hz for 3-5 min with continuous perfusion with Tyrode solution (at 1 ml/min and 36±0.1ºC) to establish a steady state. Thereafter, a number of cells was either perfused for 3 min with a total dose of 15 μmoles/3 ml of iodoacetamide ( (data not shown).
Measurements were averaged and analyzed in three phases as detailed in the legend of 1997a)), whereas DNFB does not (Westerblad & Lännergren, 1995) , we wanted to ensure complete preservation of the glycolytic flux following long chemical inhibition of a multicellular system such as the whole heart. DNFB has been shown to produce similar effects in isolated cardiomyocytes as iodoacetamide (Fowler et al., 2014) .
Creatine Kinase activity
CK activity levels were assessed using a commercial colorimetric assay kit (ab155901, Abcam) that detects kinase activity as low as 1 mU/ml (nmol/min/ml). Activity was assessed in freshly isolated cell suspensions from rat cardiomyocytes (N=3) as follows:
from each single animal, two suspensions of isolated cells were treated (i.e. one treated with buffer (control) and another with 5 mM iodoacetamide) for 5 minutes, centrifuged for 30 seconds at 27x g (37ºC) and supernatant discarded. The pellet containing cardiomyocytes was immediately frozen in liquid nitrogen and freeze-dried overnight.
Assay was performed as specified by manufacturer supplied information. Similarly, CK activity was evaluated in fresh rat cells from 3 animals without and in the presence of 20 μM of DNFB.
Statistical analysis
Data analysis and statistics were performed using Prism version 6.0 (Graphpad Software, Inc., La Jolla, CA) and SAS/STAT ® 9.2 (Statistical Analysis System Software, Institute
Inc., Cary, NC, USA).
Data are presented as mean ± SEM of all single cardiomyocytes per patient/animal or group. All data was tested for normality using the Shapiro-Wilk Test. Normality was assumed when p>0.05 and the variances were equal. Paired-and/or unpaired-sample Student's t-Test was conducted when one variable was tested between 2 groups of data.
Single classification analysis of variance (ANOVA) was performed when one variable was tested in more than 2 groups. When a significant difference was found in repeated measures 1-way ANOVA, Bonferroni post hoc testing was used to determine the location of significant differences. When more than one variable was tested in more than 2 groups a 2-way ANOVA was conducted followed by a Bonferroni post hoc test if significant differences were found. A linear mixed model was performed to gain insights into the individual trajectories of repeated measurements of each data group (e.g. intercepts and slopes) compared with controls. This model takes into account the repeated measurements within subjects. Each performed test is specified in Tables or Figure legends . The level of significance was set at p<0.05 and exact significance level (p values) are given in Supporting Tables 1 and 2 .
Results
ADP stimulates myofilament contraction in the absence of Ca
2+
To assess whether ADP alone can induce contraction in human cardiac muscle, force produced by single membrane-permeabilized cardiomyocytes from human failing hearts was measured at increasing [ADP] . ADP caused force production in the absence of Ca 2+ with maximal tension (ADP-F act ) achieved with 10 mM ADP and tension reaching 80±3%
of maximal Ca 2+ -developed tension (Fig. 1A) . Comparable to Ca 2+ , force-ADP relation curves show the common sigmoidal pattern, indicating cooperative activation (Fig. 1B) .
ADP-induced tension at 1 mM ADP amounted to 14±1% and nearly saturated at 8 mM ADP (94±3%). Half-maximal ADP-F act (EC 50 ) was 3.80±0.15 mM ADP (Fig. 1B) .
ADP increases myofilament Ca 2+ -sensitivity
Myocardial ADP levels in animal models are reported in the range of 10-50 μM in health and of 40-140 μM in disease (Tian et al., 1997b; Spindler et al., 1998; He et al., 2007) , indicative that in vivo levels of ADP are incapable of myocardial activation since in vitro mM levels of ADP are required for force generation (Fig. 1B) -sensitization, slower rates of cross-bridge cycling and high residual force recovery (Fig. 3 ).
Together these data indicate that in membrane-permeabilized cardiomyocytes the combined presence of Ca 2+ and physiological ADP levels increases cross-bridge stiffness, even at low Ca 2+ levels, which could contribute to high sarcomere stiffness and reduce LV compliance during the diastolic phase.
Re-evaluation of the influence of cross-bridges on in vitro diastolic stress with in vivo conditions
In the last decade, numerous in vitro studies assessed the diastolic properties of human HF myocardium and no evidence was found for the possible contribution of cross-bridges to the high diastolic stiffness observed in disease (van Heerebeek et al., 2012; Hamdani & Paulus, 2013) . Nevertheless, the majority of the studies thus far have been based on membrane-permeabilized myocytes, where the relatively low experimental temperature (15ºC) in concert with sarcolemma digestion that causes lattice expansion and removes important differences in intracellular milieu (such as increased ADP levels), may largely underestimate cross-bridge interactions. To overcome some of these concerns we adjusted the protocol previously reported by King et al.(King et al., 2011) , where diastolic stress was measured in rat membrane-permeabilized cardiomyocytes at 37ºC in the presence of the osmotic agent dextran to compress myofilament lattice restoring it to physiological conditions. By measuring cardiomyocyte diastolic stress, in the presence of diastolic [Ca 2+ ]
and [ADP] known to occur in disease with and without the cross-bridge inhibitor blebbistatin (30 μM), we were able to assess the contribution of cross-bridge formation to diastolic myocardial stress/stiffness. Please note that for the initial experiments in membrane-permeabilized cardiomyocytes from human ( Fig. 2) and rat (Fig. 3 ) the temperature was set at 15ºC. This relatively low temperature was used to avoid preparation deterioration and maintain the stability of the muscle preparation during several longlasting series of activation. This was shown not to be problematic for the current experiments at 37ºC as a result of lower levels of activation in concert with a relatively brief protocol.
Four protocols were performed in which rat membrane-permeabilized cardiomyocytes were stretched from 1.8 to 2.4 μm sarcomere length. Conditions used are presented in Table 1 . A representative recording is presented in Figure 4A showing diastolic force generation measured at 37ºC. Note that force is generated at 37ºC, which is not seen in the other three conditions. Comparison of 15ºC and 15ºC+Blebbistatin
confirmed the previous observations that cross-bridge contribution to diastolic stiffness is nearly absent at non-physiological conditions, with a statistical difference found at a sarcomere length of 2.4 μm (Fig. 4B) . However, comparison of 37ºC with 37ºC+Blebbistatin shows that the cross-bridge contribution is significantly higher, accounting for 76±1% of total diastolic stress averaged over all sarcomere lengths (Fig.   4B ). Together these data support that in intracellular environments where high ADP and increased diastolic [Ca 2+ ] are present, such as in the failing myocardium, the actomyosin contribution to high diastolic stiffness may be substantially higher than previously considered and potentially represent a pathophysiological mechanism of HF with impaired diastolic function.
CK-inhibited rat cardiomyocytes show impaired relaxation and augmented contractility
To investigate the impact of inactivated CK activity and the consequent increase in cytosolic ADP levels, as to replicate the cytosolic environment of HF myocardium, intact rat cardiomyocytes were perfused with the irreversible CK antagonist iodoacetamide (15 μmoles/3 ml) during pacing at 1Hz and 37ºC. CK activity was inhibited by 38±7%.
Contraction and Ca
2+
-transient were simultaneously recorded in control and iodoacetamidetreated intact rat cardiomyocytes (Fig. 5) . No significant alterations were observed between controls and iodoacetamide group at baseline (phase I) ( resulting from deterioration of the fluorescence signal over time (Table 2) .
From phase I (baseline) to phase II (initial perfusion with iodoacetamide), diastolic and systolic sarcomere length were significantly reduced by 14±2% and 38±6%, respectively ( Fig. 5B and Table 2 ), and sarcomere shortening increased by 24±5% (Fig. 5E and Table 2 ). In addition, cardiomyocyte shortening time was significantly increased without a significant change in shortening velocity ( (Fig. 5F ) and the Ca 2+ -relaxation time constant (tau) (Fig. 5G ) from phase I to II.
Between phases II and III (after iodoacetamide perfusion) diastolic and systolic sarcomere lengths decreased significantly compared with baseline and phase II ( Fig. 5B and Table 2 ). This was accompanied by 35±8% enhancement of sarcomere shortening compared with baseline (Fig. 5E ). These latter contractile changes are associated with disturbed Ca
-handling, which includes significant increases of diastolic Ca 2+ (20±6%, Fig. 5F ) with prolongation of Ca 2+ -reuptake by 50±20% (tau) (Fig. 5G ) compared with baseline (Table 2) .
Together these data indicate that inhibiting CK, which elevates cytosolic ADP, in intact cardiomyocytes leads to impaired diastolic relaxation (i.e. limited diastolic relengthening). Initially, these alterations are independent of changes in the Ca 
CK-inactivation decreases ventricular compliance in the presence of diastolic Ca
2+
Tian et al. (Tian et al., 1997a; Tian et al., 1997b) have previously shown that myocardial ADP elevation increases LVEDP and impairs myocardial relaxation in isolated rat hearts.
However, the authors argued against a role of Ca -release (Fig. 6B) . The PV slope only showed a modest increase compared to CK-inhibition (Fig. 6B) . Together, these results indicate that the combined presence of CK-inactivation and diastolic [Ca 2+ ] are needed for the observed decline in ventricular compliance in whole heart preparations.
Iodoacetamide and DNFB do not target myofilament proteins
To exclude direct effects of iodoacetamide or DNFB on myofilament proteins, membranepermeabilized rat cardiomyocytes were measured before and after incubation with both CK-inhibitors. Maximal, submaximal Ca 2+ -tension and F pas were not changed in the presence of both inhibitors, indicative that both CK-inhibitors do not directly target myofilament protein functions (Table 3) . No phosphorylation differences after iodoacetamide treatment in the intact rat cardiomyocytes ( Figure 5) -sensitivity and sarcomere stiffness in both skeletal rabbit myofibrils (Lu et al., 2001; Tesi et al., 2002; Siththanandan et al., 2006) and rat trabeculae (Martyn et al., 2007) .
Additionally, in intact rat cardiomyocytes CK-inhibition limited diastolic relaxation (Fig.   5B ). LV compliance also declined in isolated rat hearts (Fig. 6) . Similarly, it was previously shown by Tian et al.(Tian et al., 1997a; Tian et al., 1997b) that myocardial ADP accumulation increases LVEDP and impairs myocardial relaxation in isolated rat hearts.
However, these authors argued that these changes are Ca 2+ -independent (Tian et al., 1997a -dependent cross-bridge formation imposes high myocardial diastolic stiffness associated with greater than normal filling pressure, which contribute to diastolic dysfunction.
Augmented contractility following elevations of ADP and Ca
2+
On the basis of the observed diastolic impairment of intact rat cardiomyocytes we would expect a reduced fractional shortening, resulting from restricted recruitment of the FrankStarling reserve. This would decrease the preload-induced force of contraction. In contrast, contractility was increased as evidenced by enhanced shortening capacity of intact rat cardiomyocytes following CK-inactivation (Fig. 5E ). The greater than normal contractility can be explained by the increased Ca Fig. 3A) . However, prolonged CK-inhibition (phase III) still leads to increased contractility, but also significantly impairs diastolic relengthening ( Fig. 5B) that is not coupled to CKinhibition may also be present.
Enhanced actomyosin interactions lead to high diastolic stress
It has been proposed that expression of the stiffer titin isoform or its altered phosphorylation represents a major contributor to high diastolic stiffness observed in HF patients with diastolic dysfunction (van Heerebeek et al., 2012; Hamdani & Paulus, 2013) .
Within these studies, there is no evidence to support a role for altered cross-bridge interaction to high diastolic stiffness (van Heerebeek et al., 2012; Hamdani & Paulus, 2013) . In the majority of the studies membrane-permeabilized cardiomyocytes and muscle strips, with thick-and thin-filament extraction by KCl and KI, have been employed to study passive properties of HF myocardium (van Heerebeek et al., 2012; Hamdani & Paulus, 2013) . There are however limitations to the latter approaches that need to be addressed: 1)
KCl and KI treatment is designed to assess the contribution of collagen to sarcomere stiffness as it removes thick-and thin-filament anchors in the sarcomere, and thereby abolishes any contribution of the actomyosin interaction (Granzier & Irving, 1995) ; 2) chemical digestion of the sarcolemma in membrane-permeabilized cardiomyocytes causes myofilament lattice expansion (and less approximation of myosin towards actin) that decreases force generation (McDonald & Moss, 1995; Konhilas et al., 2002) ; 3) the relatively low temperature (15ºC) used in the experiments reduces cross-bridge active force, shortening velocity and power (Ranatunga & Coupland, 2010) ; 4) rapid shortening and re-lengthening procedures mechanically detach myosin from actin (Huxley & Simmons, 1971; Brenner, 1991) ; and importantly 5) membrane-permeabilized cardiomyocytes lack important contributors in the intracellular milieu of normal and failing intact cardiomyocytes. These include the in vivo diastolic Ca 2+ and cytosolic ADP. King et al.(King et al., 2011) has recently reported that cross-bridges account for up to ~30% of diastolic stress at a sarcomere length of 2.1 μm using mouse membrane-permeabilized cardiomyocytes measured at 37ºC in the presence of dextran to normalize lattice spacing. In the present study we adapted this protocol to evaluate the cross-bridge contribution to diastolic stress in rat membrane-permeabilized cardiomyocytes under disease conditions, including those where metabolic function is affected that elevates ADP in the presence of diastolic Ca
2+
, and showed that cross-bridges greatly contribute to diastolic stress (Fig. 4) .
Our data support the idea that cross-bridges may slow myocardial relaxation and impose high diastolic stiffness in disease, and in concert with titin and other diastolic mediators, contribute to diastolic dysfunction in HF patients. Importantly our results support the notion that the diastolic phase is not purely a passive process, but is accompanied by active stress.
Limitations
At present, we are unable to directly control intracellular ADP concentration in the intact cardiomyocytes and whole heart preparations. To increase cytosolic ADP, we opted for the use of two well known drugs that inhibit the CK reaction, i.e. iodoactemide and DNFB.
Iodoacetamide allows us to estimate ADP elevations due to its well-characterized effects on the ATP-regeneration system (Tian et al., 1997a) . Based on previous findings using similar amounts of iodoactemide (Tian et al., 1997a) , ADP is estimated not to exceed 73 μM in our experiments, while ATP, PCr, inorganic phosphate and pH levels are unaltered. A limitation of iodoactemide which makes it unsuitable for whole heart experiments, is that it unspecifically targets enzymes of the glycolytic reaction (Tian et al., 1997a) . This is not problematic in single cells because of the short duration of the experiment (3 min). In contrast, this might be detrimental in the whole heart experiments, which required longer periods of CK-inhibition (30 min). Therefore, DNFB was used in those experiments, as it does not target enzymes of the glycolytic pathway (Westerblad & Lännergren, 1995) .
However, using DNFB we are unable, to our knowledge, to carefully estimate the expected intracellular ADP concentration. We believe that overall the effects of both drugs are interchangeable between experiments, which is partly supported by similar inhibition of the CK reaction (~40%).
Conclusion
Based on our experimental data, we propose that conditions which elevate myocardial ADP and Ca 
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Translational Perspective
Here we show that actomyosin-related force development may be an important contributor to high diastolic stiffness and may explain the development of diastolic dysfunction in environments where high ADP and increased diastolic [Ca 2+ ] are present, such as in the failing myocardium. These findings establish a clear link between deficits of myocardial energy reserve and disturbed Ca 2+ -handling, which together leads to inappropriate crossbridge formation and high diastolic stiffness. These findings may provide insight in how energy-sparing therapies (that reduce cellular ATP usage), such as beta-blockers, angiotensin-receptor blockers and angiotensin converting enzyme inhibitors, improve symptoms and reduce mortality in congestive HF patients (McMurray & Pfeffer, 2005) .
Our data highlight the need for more targeted therapies aimed at lowering myocardial ADP levels to improve the prognosis of human HF. PCr, Phosphocreatine; pH was adjusted to 7.1 at 15ºC and at 37ºC with KOH and ionic strength was adjusted to 180 mM with KCl; 2 mM free Mg 2+ , 10 mM MgATP, 7 mM EGTA and 100 mM BES were present in all solutions; Experiments performed at 15ºC were used to mimic conditions currently employed to study diastolic stiffness, while experiments at 37ºC better recapitulate the in vivo diseased heart. Table S2 . 7 heart samples from adult wild-type male Wistar rats were used; 17 to 18 (Ctrl-group) and 17 to 20 (IA-group) cardiomyocytes were analysed. ) in the absence (gray exponential curve) and presence of Blebbistatin (15ºC + Blebbistatin; dashed gray exponential curve). All solutions contained 10 mM ATP.
Comparison of 37ºC with 37ºC+Blebbistatin shows that the cross-bridge contribution accounts for 76±1% of total diastolic stress averaged over all sarcomere lengths. Data was compared using unpaired t-Test within independent groups measured at similar temperature for each individual sarcomere length. Table 2 . * p<0.05 versus Phase I. Data was compared using 1-way ANOVA followed by Bonferroni post hoc test. 7 heart samples from adult wild-type male Wistar rats were used; 17 to 18 (Ctrl-group) and 17 to 20 (IAgroup) cardiomyocytes were analysed. 
